In-Patient Study of Thrombocytopenia Event Induced by Ceftriaxone, Ranitidine and Ketorolac

Authors

  • Editor AJPT

Abstract

Introduction: Drug-induced thrombocytopenia en occurs during the patient hospitalized. the pharmacoepidemiology study, it can be seen thrombocytopenia induced by the use of ce axone, ranitidine and ketorolac.

Objective: To assess thrombocytopenia induced by the use of ce axone, ranitidine and ketorolac.

Methods: e assessment was done by identifying patients medical records were obtained retrospectively and concurrent. Furthermore, analysis of the data was assessed by case control study.

Results: In-patients using ce riaxone, ranitidine and ketorolac risk of decreased platelets to the potential onset of thrombocytopenia. From data taken retrospectively obtained results of the odds ratio was 1.8. While the data taken concurrently, obtained odds ratio greater than 2.8.

Conclusion: pharmacoepidemiology studies with odds ratio analysis approach is known that the use of a ce riaxone, ranitidine and ketorolac increasese the risk of decreased platelets potentially toward thrombocytopenia.

Downloads

Published

2021-10-17

Issue

Section

Articles